+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds



Inhibition profiling of human carbonic anhydrase II by high-throughput screening of structurally diverse, biologically active compounds



Journal of Biomolecular Screening 11(7): 782-791



Human carbonic anhydrase II (CA II), a zinc metalloenzyme, was screened against 960 structurally diverse, biologically active small molecules. The assay monitored CA II esterase activity against the substrate 4-nitrophenyl acetate in a format allowing high-throughput screening. The assay proved to be robust and reproducible with a hit rate of approximately 2%. Potential hits were further characterized by determining their IC(50) and K(d) values and tested for nonspecific, promiscuous inhibition. Three known sulfonamide CA inhibitors were identified: acetazolamide, methazolamide, and celecoxib. Other hits were also found, including diuretics and antibiotics not previously identified as CA inhibitors, for example, furosemide and halazone. These results confirm that many sulfonamide drugs have CA inhibitory properties but also that not all sulfonamides are CA inhibitors. Thus many, but not all, sulfonamide drugs appear to interact with CA II and may target other CA isozymes. The screen also yielded several novel classes of nonsulfonamide inhibitors, including merbromin, thioxolone, and tannic acid. Although these compounds may function by some nonspecific mechanism (merbromin and tannic acid), at least 1 (thioxolone) appears to represent a genuine CA inhibitor. Thus, this study yielded a number of potentially new classes of CA inhibitors and preliminary experiments to characterize their mechanism of action.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012867451

Download citation: RISBibTeXText

PMID: 16858005

DOI: 10.1177/1087057106289403


Related references

High-throughput screening against ~6.1 million structurally diverse, lead-like compounds to discover novel ROCK inhibitors for cerebral injury recovery. Molecular Diversity 20(2): 537-549, 2015

High-throughput small molecule screening reveals structurally diverse compounds that inhibit the growth of Escherichia coli O157:H7 in vitro. Journal of Food Protection 74(12): 2148-2156, 2012

The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors. Journal of Medicinal Chemistry 53(2): 850-854, 2010

Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorganic & Medicinal Chemistry 15(22): 6900-6908, 2007

Complexes With Biologically Active Ligands. Part 6 Ni(II) Coordination Compounds of Hydrazine and Heterocyclic Sulfonamides as Inhibitors of the Zinc Enzyme Carbonic Anhydrase. Metal-Based Drugs 3(3): 143-148, 1996

Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Bioorganic & Medicinal Chemistry Letters 19(23): 6649-6654, 2010

Complexes with biologically active ligands. Part 4. Coordination compounds of chlorothiazide with transition metal ions behave as strong carbonic anhydrase inhibitors. Metal-Based Drugs 3(2): 79-83, 1996

Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase. Bioorganic & Medicinal Chemistry 20(18): 5550-5558, 2013

Complexes With Biologically Active Ligands. Part 10 Inhibition of Carbonic Anhydrase Isozymes I and II With Metal Complexes of Imidazo[2,1-b ]-1,3,4-Thiadiazole-2-Sulfonamide. Metal-Based Drugs 4(1): 19-26, 1997

The inhibition of human carbonic anhydrase II by some organic compounds. Biochimica et Biophysica Acta 829(2): 202-208, 1985

The inhibition of human carbonic anhydrase ii ec 4.2.1.1 by some organic compounds. Biochimica et Biophysica Acta 829(2): 202-208, 1985

Inhibition by cupric ions of 18O exchange catalyzed by human carbonic anhydrase II. Relation to the interaction between carbonic anhydrase and hemoglobin. Journal of Biological Chemistry 256(18): 9466-9470, 1981

Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety. Bioorganic & Medicinal Chemistry 21(19): 5973-5982, 2014

Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. Bioorganic & Medicinal Chemistry 22(5): 1586-1595, 2014

Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Bioorganic & Medicinal Chemistry Letters 16(2): 437-442, 2005